Burkay Adalig

Impact of disease progression on individual IPSS trajectories and consequences of immediate versus delayed start of treatment in patients with moderate or severe LUTS associated with BPH

Salvatore DʼAgate, Timothy H. Wilson, Burkay Adalig et al. · World Journal of Urology · 2019 · 23 citations · Full text

Medicine, Pharmacotherapy, Urology +14

Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education ( <scp>PROBE</scp> ) <scp>II</scp> survey

P J Ertel, Burkay Adalig, Ipek Demircan et al. · International Journal of Clinical Practice · 2016 · 17 citations · Full text

Medicine, Endocrinology, Urology +10

Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany

Christoph Eisen, Zrinka Lulic, Juan Palacios‐Moreno et al. · International Journal of Clinical Pharmacology and Therapeutics · 2019 · 16 citations · Full text

Medicine, Pharmacotherapy, Urology +14